Abstract
The successful use of targeted ultrasound contrast agents (USCAs) for qualitative US-based imaging has been shown by several academic and industrial research groups in different animal models. Furthermore, techniques have been developed that enable the in-vivo quantification of targeted microbubbles (MBs). USCAs for quantitative functional and molecular imaging in small animals can be used for a more detailed characterization of new and established disease models and provide quantitative biological insights into the interaction between drug and target or target and disease in living animals.
The advantages of such contrast agents in research and development are seen to be as follows:
-
new functional or molecular findings in the complex biology of disease development
-
these findings can lead to new therapeutic strategies or drug candidates
-
a better understanding of the treatment effects of new and existing drug candidates
-
a more sensitive and specific characterization of early treatment effects in living animals
-
identification of in-vivo biomarkers for translational medicine
Further outcomes are seen in speeding up the evaluation of new drug compounds and in a reduction of the number of animals used for biomedical research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bauer A, Blomley M, Leen E et al (1999) Liver-specific imaging with SHU 563 A: Diagnostic potential of a new class of ultrasound contrast media. Eur Radiol 9(Suppl 3):S349-S352
Berwing K, Schleppe M (1988) Echocardiographic imaging of the left ventricle by peripheral intravenous injection of echo contrast agent. Amer Heart 115:399-408
Chiang CW, Lin FC, Fu M et al (1986) Importance of adequate gas-mixing in contrast echocardio-graphy. Chest 89:723-726
Choi SH, Kono Y, Corbeil J et al (2004) Model to quantify lymph node enhancement on indirect sonographic lymphography. AJR Am J Roentgenol 183:513-517
Christiansen JP, Leong-Poi H, Klibanov AL et al (2002) Noninvasive imaging of myocardial reper-fusion injury using leukocyte-targeted contrast echocardiography. Circulation 105:1764-1767
Cosgrove D (1996) Warum brauchen wir Kontrastmittel f ür den Ultraschall? Clin Radiol 51 (Suppl 1):1-4
Dayton PA, Ferrara KW (2002) Targeted imaging using ultrasound. J Magn Reson Imaging 16:362-377
De Jong N (1997) Physics of microbubble scattering. In: Nanda NC, Schlief R, Goldberg BB (eds) Advances in echo imaging using contrast enhancement, 2nd edn. Kluwer, Dordrecht, pp 39-64
Ellegala DB, Leong-Poi H, Carpenter JE et al (2003) Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to αvβ3 . Circulation 108:336-341
Fischer NG, Christiansen JP, Klibanov AL et al (2002) Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol 40:811-819
Fox RJ, Ransohoff RM (2004) New directions in MS therapeutics: vehicles of hope. Trends Immunol 25:632-636
Gramiak R, Shah P (1968) Echocardiography of the aortic root. Invest Radiol 3:356-366
Hauff P, Reinhardt M, Jeschke J et al (1994) Indirekte Lymphographie mit einem neuen Ultra-schallkontrastmittel (USKM). Ultraschalldiagnostik ’94, Drei-L änder-Treffen, Basel, Schweiz, 26-29.10.1994. Bildgebung/lmaging 61(Suppl 2):17
Hauff P, Fritzsch T, Reinhardt M et al (1997) Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Invest Radiol 32:94-99
Hauff P, Stephens A, Br äutigam M (2003) New imaging probes. In: Debatin JF, Hricak H, Niendorf HP (eds) MRI: from current knowledge to new horizon. Excerpta Medica, pp 259-268
Hauff P, Reinhardt M, Briel A et al (2004) Molecular targeting of lymph nodes with L-selectin ligand-specific us contrast agent: a feasibility study in mice and dogs. Radiology 231:667-673
Hauff P, Seemann S, Reszka R et al (2005) Evaluation of gas-filled microparticles and sonoporation as gene delivery system: Feasibility study in rodent tumor model. Radiology 236:572-578
Keller MW, Glasheen W, Teja K et al (1988) Myocardial contrast echocardiography without signif-icant hemodynamic effects or reactive hyperemia: a major advantage in the imaging of regional myocardial perfusion. J Amer Coll Cardiol 12:1039-1047
Klibanov AL (1999) Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev 37:139-157
Klibanov AL (2005) Ligand-carrying gas-filed microbubbles: ultrasound contrast agents for tar-geted molecular imaging. Bioconjugate Chem 16:9-17
Korpanty G, Grayburn PA, Shohet RV et al (2005) Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol 31:1279-1283
Lange L, Fritzsch T, Hillmann J et al (1986) Right-heart echocontrast in the anesthetized dog after i.v. administration of a new standardized sonographic agent, 3rd communication: Comparison of various contrast agents employed in contrast echocardiography. Arzneim-Forsch 36: 1037-1040
Lanza GM and Wickline SA (2001) Targeted ultrasonic contrast agents for molecular imaging and therapy. Prog Cardiovasc Dis 44:13-31
Lee F and Ginzton L (1983) A central nervous system complication of contrast echocardiography. J Clin Ultrasound 11:292-294
Leong-Poi H, Christiansen J, Klibanov AL et al (2003) Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to αv -Integrins. Circulation 107:455-460
Lindner JR, Coggins MP, Kaul S et al (2000) Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. Circulation 101:668-675
Lindner JR, Dayton PA, Coggins MP et al (2000) Noninvasive imaging of inflammation by ultra-sound detection of phagocytosed microbubbles. Circulation 102:531-538
Lindner JR, Song J, Xu F et al (2000) Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 102:2745-2750
Lindner JR, Song J, Christiansen J et al (2001) Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 104:2107-2112
Linker R, Reinhardt M, Bendszus M et al (2005) In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE). J Autoimmunity 25:199-205
M äurer M, Linker R, Hauff P et al (2003) Imaging of ICAM-1 in experimental autoimmune ene-cephalomyelitis (EAE) with a specific ultrasound contrast agent. Neurology 60:A423
M äurer M, Linker R, Reinhardt M et al (2005) M öglichkeiten target-spezifischer molekularer Bildgebung mit Ultraschallkontrastmitteln. Radiologe 45:560-568
Mattrey RF (1983) Perfluorochemicals as liver- and spleen-seeking ultrasound contrast agents. J Ultrasound Med 2:173-176
Mattrey RF, Kono Y, Baker K et al (2002) Sentinel lymph node imaging with microbubble ultra-sound contrast Material. Acad Radiol 9(Suppl 1):S231-S235
Oussoren C, Zuidema J, Crommelin DJ et al (1997) Lymphatic uptake and biodistribution of lipo-somes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose. Biochim Biophys Acta 1328:261-272
Reinhardt M, Fritzsch T, Heldmann D et al (1993) Use of microcapsules as contrasting agents in colour Doppler sonography. WO 93/25241
Reinhardt M, Hauff P, Linker RA et al (2005a) Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ). Neuroimage 27:267-278
Reinhardt M, Hauff P, Briel A et al (2005b) Sensitive Particle Acoustic Quantification (SPAQ): a new ultrasound-based approach for the quantification of ultrasound contrast media in high concentrations. Invest Radiol 40:2-7
Rychak JJ et al (2007) Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging 6:289-296
Schirner M, Menrad A, Stephens A et al (2004) Molecular imaging of tumor angiogenesis. Ann N Y Acad Sci 1014:67-75
Schlief R (1997) Echo-enhancing agents: their physics and pharmacology. In: Nanda NC, Schlief R, Goldberg BB (eds) Advances in echo imaging using contrast enhancement, 2nd edn. Kluwer, Dordrecht, pp 85-113
Schrope V, Newhouse VL, Uhlendorf V (1992) Simulated capillary blood flow measurement using a non-linear ultrasonic contrast agent. Ultrasonic Imaging 14:134-158
Schumann PA, Christiansen JP, Quigley RM et al (2002) Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 37:587-593
Simionescu M (2000) Structural, biochemical and functional differentiation of the vascular en-dothelium. In: Risau W, Rubanyi GM (eds) Morphogenesis of the endothelium. Harwood, Amsterdam, pp 1-22
Simon RH, Ho SY, D’Arrigo J et al (1990) Lipid-coated ultrastable microbubbles as a contrast agent in neuro-sonography. Invest Radiol 25:1300-1304
Streeter PR, Rouse BT, Butcher EC (1988) Immunohistologic and functional characterization of a vascular addressing involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 107:1853-1862
Takeuchi M, Ogunyanki K, Pandian NG et al (1999) Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): in vivo experimental echocardiographic studies. J Am Soc Echocardiogr 12:1015-1021
Tiemann K, Pohl C, Schlosser T et al (2000) Stimulated acoustic emission: pseudo-Doppler shifts seen during the destruction of non-moving microbubbles. Ultrasound Med Biol 26:1161-1167
Uhlendorf V, Hoffmann C (1994) Nonlinear acoustic response of coated microbubbles in diagnostic ultrasound. Ultrasonics Symposium, Cannes, France, pp 1559-1562
Villanueva FS, Jankowski RJ, Klibanov S et al (1998) Microbubbles targeted to intercellular adhe-sion molecule-1 bind to activated coronary artery endothelial cells. Circulation 98:1-5
Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316-333
Weller GER, Lu E, Csikari MM (2003) Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 108:218-224
Weller GER, Wong MKK, Modzelewski RA et al (2005) Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 65:533-539
Wright WH, McCreery TP, Krupinski EA et al (1998) Evaluation of new thrombus-specific ultra-sound contrast agent. Acad Radiol 5(Suppl 1):S240-S242
Wu Y, Unger EC, McCreery TP et al (1998) Binding and lysing of blood clots using MRX-408. Invest Radiol 33:880-885
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hauff, P., Reinhardt, M., Foster, S. (2008). Ultrasound Contrast Agents for Molecular Imaging. In: Semmler, W., Schwaiger, M. (eds) Molecular Imaging I. Handbook of Experimental Pharmacology, vol 185/1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-72718-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-540-72718-7_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-72717-0
Online ISBN: 978-3-540-72718-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)